Delivery Order SPE2DB22D1017-SPE2DB25FYSGU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,426.99 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $53,908.10 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a $25.8K delivery order on August 20, 2025, for Biktarvy 50-200-25 mg tablets (30-count units), with completion scheduled for August 21, 2025. This competitive, non-set-aside award was issued under firm fixed pricing terms and represents a single delivery order transaction. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,548.16 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count unit dose packaging). The contract, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed-price delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order is not set-aside and was competitively awarded. AmerisourceBergen, headquartered...
- The Defense Logistics Agency awarded a $32,329.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) with a completion date of August 7, 2025. This non-set-aside competitive award represents a pharmaceutical supply delivery supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $24,313.46 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30s. This is a firm fixed price delivery order with an ultimate completion date of September 24, 2025, issued on September 23, 2025. The award carries no set-aside designation and represents a competitive award to the pharmaceutical distributor. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a $6,373.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 21, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This non-set-aside contract, with an ultimate completion date of May 22, 2025, represents a pharmaceutical delivery under AmerisourceBergen's broader federal medical supply agreements. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a $78,499.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) with an ultimate completion date of July 1, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,376.16 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This firm fixed-price delivery order, issued on September 24, 2025, represents a non-competitive award and constitutes a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $24,229.80 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 tablets per unit. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 2, 2025. The contract specifies AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. This delivery order represents a child contract under...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYSGUDelivery Order
The Defense Logistics Agency awarded a $24,069.09 firm fixed price delivery order to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) with a completion date of September 30, 2025. This non-set-aside contract represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters and primary distribution hub for federal medical procurement operations. This delivery order is part of AmerisourceBergen's comprehensive $999,999,999 Indefinite Delivery Contract (designated SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen has established itself as a critical federal vendor through competitive contract awards covering a broad spectrum of pharmaceutical products, including specialty medications, vaccines, and medical supplies across multiple therapeutic domains. The company supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract arrangement, positioning it among the primary pharmaceutical distributors for Department of Defense medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.1k | 9/29/25 |